Atlas Trials

Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO

Clinical trial NCT02387788 · COMPLETED

Trial details

NCT number
NCT02387788
Sponsor
Aerpio Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Retinal Vein Occlusion
Start date
2015-01-01
Primary completion
2017-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.